
Morningside Venture Partners
North America, New York, United States, New York
Description
Morningside Venture Partners focuses on partnering with talented entrepreneurs to develop the next wave of truly great companies.
Investor Profile
Morningside Venture Partners has backed more than 19 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 16% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series B, Series A rounds (top funding stages).
- Majority of deals are located in United States, China, United Kingdom.
- Strong thematic focus on Biotechnology, Medical, Therapeutics.
Stage Focus
- Series Unknown (32%)
- Series B (16%)
- Series A (16%)
- Seed (16%)
- Series C (11%)
- Series D (5%)
- Angel (5%)
Country Focus
- United States (37%)
- China (26%)
- United Kingdom (26%)
- Brazil (5%)
- Israel (5%)
Industry Focus
- Biotechnology
- Medical
- Therapeutics
- Health Care
- Saas
- Life Science
- Advertising
- Artificial Intelligence (Ai)
- Machine Learning
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.